Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.42

-1.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Thomas who wrote (68)	4/4/1997 7:03:00 AM
From: Douglas	of 455

You probably already know the following, but here is what little information I obtained when I called Procept's Investor Relations: Phase I's (Belgium and London) will be completed at end of 2nd quarter with results reported in 3rd quarter. No comment on Phase II. Results will be evaluated prior to a decision. I noticed that in their 10K that discussions are underway with the National Institutes of Health and the British Medical Research Council to secure support for the clinical program (page 6). Number of company employees is approximately 40. When searching the web I found a reference to Dr. Pallai, Director of Chemistry at Procept leaving to go to another company called ArQule(ARQL). Dr. Pallai was involved with the combinatorial library design for identifying and discovering new drugs. websmart.com:8810/ss-news/CX388005.htm Annual Report will be out in May.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next